Russia might as well have won the race for the first-ever coronavirus vaccine. President Vladimir Putin has confirmed the registration of what he terms to be the first-ever coronavirus in the world. According to the Russian strong man, the vaccine forms a stable immunity and passed all the necessary checks.
Russia Corona virus
Putin said it has already been tested on one of his daughters in a bid to wrap up support for the vaccine and affirm its credibility. Russia completed clinical trials in less than two months with phase three trials poised to commence soon. The United Arab Emirates, the Philippines, and Saudi Arabia have already confirmed plans to participate in the trials.
The Russian vaccine was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology. According to the World Health Organization, it was part of 26 other candidate vaccines in the clinical evaluation stage.
Researchers and world powers have already downplayed news of a vaccine out of Russia. The fact that Russia is yet to publish the coronavirus data continues to arouse concerns. In addition, Russia is yet to indicate the long term effects of the vaccine as well as its safety standards. The World Health Organization, on its part, maintains it is in close contact with Russia Health Authorities about possible pre-qualification of the vaccine.
Coronavirus Arms Race
Russia has had to come out fighting over claims it is in an arms race over a coronavirus vaccine. International skepticism has been building up over Russia’s ability to develop an effective and safe vaccine. For instance, Whitehouse coronavirus advisor, Anthony Fauci has already called to question Russia and China’s approaches to developing the highly sensitive COVID-19 vaccine.
News of A Russia Coronavirus vaccine comes on the heels of the U.S government striking a $1.5 billion deal for a highly prospective coronavirus vaccine from Moderna Inc.; The Company is to supply 100 million doses of its experimental vaccine for COVID-19.
Moderna has already secured a $955 million financing from the government for the development of the vaccine. If approved the vaccine will go for $15 a dose or $30 for a two-dose regimen.
